(Q44202423)

30 November 2017

title

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome (English)

1 reference

cytomegalovirus retinitis

30 November 2017

0 references

1 reference

2

1 reference

30 November 2017

Cochereau-Massin I

1

1 reference

30 November 2017

Lautier-Frau M

3

1 reference

30 November 2017

Zazoun L

4

1 reference

30 November 2017

Marcel P

5

1 reference

30 November 2017

Robinet M

6

1 reference

30 November 2017

Matheron S

7

1 reference

30 November 2017

Katlama C

8

1 reference

30 November 2017

Gharakhanian S

9

1 reference

30 November 2017

Rozenbaum W

10

1 reference

30 November 2017

publication date

1 September 1991

1 reference

30 November 2017

1 reference

30 November 2017

volume

98

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1348-53; discussion 1353-5

1 reference

Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS)

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Intravitreal ganciclovir in CMV retinitis: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Survival trends for patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Atypical retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Long-term intravitreal ganciclovir for cytomegalovirus retinitis in a patient with AIDS. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Rhegmatogenous Retinal Detachment Complicating Cytomegalovirus Retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Microvascular aspects of acquired immune deficiency syndrome retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Ocular toxicity of multiple intravitreal DHPG injections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932135-3

7 January 2021

10.1016/S0161-6420(91)32135-3

Identifiers

DOI

0 references

1 reference